Serum and lung tissue selenium measurements in subjects with lung cancer from Xuanwei, China

Chinese Journal of Lung Cancer

Volumn 14, Issue 1, 2011, Pages 39-42

  Zhou, Lan ^a   Huang, Yunchao ^a   Wang, Zhu ^b   Ye, Lianhua ^a   Hou, Wenjun ^c   Yang, Kaiyun ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Xuanwei People's Hospital of Yunnan Province   (China)

Author keywords

Lung neoplasm; Selenium; Xuanwei

Indexed keywords

SELENIUM;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER INCIDENCE; CANCER PATIENT; CANCER STAGING; CANCER TISSUE; CHINA; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; FLUOROMETRY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MINERAL BLOOD LEVEL; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; CASE-CONTROL STUDIES; CHINA; FEMALE; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; SELENIUM;

EID: 78751693573     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.l009-3419.2011.01.08     Document Type: Article

References (15)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin, 2005, 55(2): 74-108.
2. Hao JH, Huang YC, Ren HX, et al. Trend analysis of lung cancer mortality in areas with high incidence form 1973 to 2005. Chin General Pract, 2009, 12(24): 2279-2282.
3. He XZ. Coal-fired indoor air pollution and lung cancer genetic susceptibility-the etiology research of lung cancer in Xuanwei for 22 years. J Pract Oncol, 2000, 16(6): 369-370.
4. Shamberger RJ, Frost DV. Possible protective effect of selenium against human cancer. Can Med Assoc J, 1969, 100(14): 682.
5. Schrauzer GN, White DA, Schneider CJ. Cancer mortality correlation studies - III: statistical associations with dietary selenium intakes. Bioinorg Chem, 1977, 7(1): 23-31.
6. Li WG, Xie JR, Yu SY, et al. Relationship between the geographical distribution characteristics and selenium levels of primary liver cancer patients in Qidong. Chin J Oncol, 1986, 8(4): 262.
7. Knekt P, Aromaa A, Maatela J, et al. Serum selenium and subsequent risk of cancer among Finnish men and women. J Natl Cancer Inst, 1990, 82(10): 864-868.
8. Knekt P, Marniemi J, Teppo L, et al. Is low selenium status a risk factor for lung cancer? Am J Epidemiol, 1998, 148(10): 975-982.
9. Sun SZ, Cao JX, Li MZ, et al. Studies on the selenium in environment of endemic disease areas-the levels and forms of selenium. J Hygiene Res, 1995, 24(3): 141-147.
10. Shor-Posner G, Miguez MJ, Pineda LM, et al. Impact of selenium status on the pathogenesis of mycobacterial disease in HIV-1-infected drug users during the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr, 2002, 29(2): 169-173.
11. Chen Q, Wang NF, Yan SH, et al. Reference values for blood, hair and organ selenium levels in adults of Beijing. Chin J Prev Med, 1994, 28(5): 267-271.
12. Zhou L, Huang YC, Lei YJ, et al. Effects of selenium and reduced glutathione on the proliferation and apoptosis of lung cancer cell line XWLC-05. Chin J Lung Cancer, 2008, 11(4): 551-554.
13. Fischer JL, Lancia JK, Mathur A, et al. Selenium protection from DNA damage involves a Ref1/p53/Brca1 protein complex. Anticancer Res, 2006, 26(2A): 899-904.
14. El-Bayoumy K, Das A, Narayanan B, et al. Molecular targets of the chemopreventive agent 1,4-phenylenebis (methylene)-selenocyanate in human non-small cell lung cancer. Carcinogenesis, 2006, 27(7): 1369-1376.
15. Smith ML, Lancia JK, Mercer TI, et al. Selenium compounds regulate p53 by common and distinctive mechanisms. Anticancer Res, 2004, 24(3a): 1401-1408.